Athos Capital Ltd

Position in RNA — Atrium Therapeutics, Inc.

CIK 1681662 HONG KONG, K3

Position in RNA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,443,492

New position

Shares Held

107,965

first reported quarter

Ownership

0.631%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Athos Capital Ltd holds $22,540,765 across 4 Biotechnology names. RNA ranks #4 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	695,500	$10,056,930
2	ACLX	Arcellx, Inc.	64,900	$7,451,818
3	RVMD	Revolution Medicines, Inc.	36,900	$3,588,525
4	RNA	Atrium Therapeutics, Inc. This page	107,965	$1,443,492

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,443,492	107,965	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.